Magic Mouth Rinse

Phase 2Small molecule

Magic Mouth Rinse is one of 4 small molecule programs targeting Chemotherapy-Induced Oral Mucositis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chemotherapy-Induced Oral MucositisActive, not recruiting

Chemotherapy-Induced Oral MucositisPhase 2

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Chemotherapy-Induced Oral Mucositis

#DrugCompanyPhaseTrials

Propolis

IIndonesia University

Phase 2

1 2

Chamomile

HHams Hamed Abdelrahman

Phase 2

1 3

Quercetin

Magic Mouth Rinse

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chemotherapy-Induced Oral Mucositis1 trial

Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis

Terminated·OOral Defense, LLC·Phase 2·NCT02606994·1 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Magic Mouth Rinse. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Magic Mouth Rinse compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Magic Mouth Rinse. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Oral Defense, LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: OOral Defense, LLC

Magic Mouth Rinse

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chemotherapy-Induced Oral Mucositis1 trial

References

Drug Info

Quick Facts

Related News